Compliance Rate
Compliance Rate
66.67%
Compliant submissions
2
Incompliant submissions
1
Total trials
3
My Organizations' Clinical Trials
Showing 1250 of 1308 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 11/17/20
Due: 11/17/21
Phase: N/A
Priority: Normal
Start: 04/13/18
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 01/07/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 09/10/19
End: 09/05/23
Due: 09/05/24
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 07/10/24
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 05/13/16
End: 08/14/18
Due: 08/14/19
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/14/17
Due: 07/14/18
Phase: N/A
Priority: Normal
Start: 06/30/01
End: 01/31/06
Due: 01/31/07
Phase: N/A
Priority: Normal
Start: 04/29/19
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 12/01/26
End: 12/01/28
Due: 12/01/29
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 02/29/28
Due: 02/28/29
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 12/31/10
Due: 12/31/11
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
Phase: N/A
Priority: Normal
Start: 07/14/20
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 05/23/17
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 05/03/18
End: 10/31/20
Due: 10/31/21
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 02/01/26
Due: 02/01/27
Phase: N/A
Priority: Normal
Start: 02/23/19
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 04/30/13
Due: 04/30/14